EPISODE · Sep 12, 2025 · 23 MIN
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
from Oncology Today with Dr Neil Love
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publications here.
Embed this episode
Ready to play
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
0:00
23:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 23 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on September 12, 2025.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!